Exhibits
10-K
from 10-K
130 pages
10-K
03/03/22
EX-21.1
from 10-K
1 page
Subsidiaries of the registrant
03/03/22
EX-23.1
from 10-K
1 page
Consent of expert or counsel
03/03/22
EX-10.24
from 10-K
2 pages
Entasis Therapeutics Holdings Inc. Second Amended Non-Employee Director Compensation Policy
03/03/22
EX-10.25
from 10-K
2 pages
Amendment to Incentive Stock Option Agreement (Employees) Issued Under Amended and Restated Stock Incentive Plan
03/03/22
EX-10.26
from 10-K
2 pages
Amendment to Incentive Stock Option Agreement (Senior Management) Issued Under Amended and Restated Stock Incentive Plan
03/03/22
EX-10.27
from 10-K
2 pages
Amendment to Nonqualified Stock Option Agreement (Employees) Issued Under Amended and Restated Stock Incentive Plan
03/03/22
EX-10.28
from 10-K
2 pages
Amendment to Nonqualified Stock Option Agreement (Senior Management) Issued Under Amended and Restated Stock Incentive Plan
03/03/22
EX-10.29
from 10-K
2 pages
Amendment to Option Agreement Issued Under 2018 Equity Incentive Plan
03/03/22
EX-10.30
from 10-K
2 pages
Amendment to Restricted Stock Unit Grant Agreement Issued Under 2018 Equity Incentive Plan
03/03/22
EX-10.31
from 10-K
8 pages
Option Agreement
03/03/22
EX-10.32
from 10-K
9 pages
Entasis Therapeutics Holdings Inc. 2018 Equity Incentive Plan Restricted Stock Unit Grant Agreement (Employee/D & O)
03/03/22
EX-10.33
from 10-K
1 page
Exhibit B to Unanimous Written Consent Dated November 10, 2021 Memorandum
03/03/22
EX-31.1
from 10-K
1 page
Management certification of annual or quarterly disclosure
03/03/22
EX-31.2
from 10-K
1 page
Management certification of annual or quarterly disclosure
03/03/22
EX-32.1
from 10-K
1 page
Management certification of financial report
03/03/22
